Expanding Pyrimidine Diphosphosugar Libraries Via Structure-Based Nucleotidylyltransferase Engineering

In vitro "glycorandomization" is a chemoenzymatic approach for generating diverse libraries of glycosylated biomolecules based on natural product scaffolds. This technology makes use of engineered variants of specific enzymes affecting metabolite glycosylation, particularly nucleotidylyltr...

Full description

Saved in:
Bibliographic Details
Published inProceedings of the National Academy of Sciences - PNAS Vol. 99; no. 21; pp. 13397 - 13402
Main Authors Barton, William A., Biggins, John B., Jiang, Jiqing, Thorson, Jon S., Nikolov, Dimitar B.
Format Journal Article
LanguageEnglish
Published United States National Academy of Sciences 15.10.2002
National Acad Sciences
Subjects
Online AccessGet full text

Cover

Loading…
More Information
Summary:In vitro "glycorandomization" is a chemoenzymatic approach for generating diverse libraries of glycosylated biomolecules based on natural product scaffolds. This technology makes use of engineered variants of specific enzymes affecting metabolite glycosylation, particularly nucleotidylyltransferases and glycosyltransferases. To expand the repertoire of UDP/dTDP sugars readily available for glycorandomization, we now report a structure-based engineering approach to increase the diversity of α-D-hexopyranosyl phosphates accepted by Salmonella enterica LT2 α-D-glucopyranosyl phosphate thymidylyltransferase (Ep). This article highlights the design rationale, determined substrate specificity, and structural elucidation of three "designed" mutations, illustrating both the success and unexpected outcomes from this type of approach. In addition, a single amino acid substitution in the substrate-binding pocket (L89T) was found to significantly increase the set of α-D-hexopyranosyl phosphates accepted by Epto include α-D-allo-, α-D-altro-, and α-D-talopyranosyl phosphate. In aggregate, our results provide valuable blueprints for altering nucleotidylyltransferase specificity by design, which is the first step toward in vitro glycorandomization.
Bibliography:ObjectType-Article-2
SourceType-Scholarly Journals-1
ObjectType-Feature-1
content type line 23
To whom correspondence may be addressed. E-mail: dimitar@ximpact3.ski.mskcc.org or jsthorson@pharmacy.wisc.edu.
Data deposition: The atomic coordinates and structure factors have been deposited in the Protein Data Bank, www.rcsb.org (PDB ID codes , , and ).
Communicated by Samuel J. Danishefsky, Memorial Sloan–Kettering Cancer Center, New York, NY
ISSN:0027-8424
1091-6490
DOI:10.1073/pnas.192468299